Apotex Warning Letter Demands List Of Products That Might Enter U.S.
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA already has Bangalore, India plant on an import alert, but the agency may be preparing to go after API from the facility as well after finding persistent use of questionable testing data.